[On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002118:Calcium / Q000037:antagonists & inhibitors; D003331:Coronary Vessels / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D009570:Nitriles / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects*; D011299:Prenylamine / Q000494:pharmacology*; D011984:Sensory Receptor Cells / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil; D011299:Prenylamine; D002118:Calcium
Zum Wirkungsmechanismus neuartiger Koronadilatatoren mit gleichzeitig Sauerstoff-einsparenden Myokard-Effekten, Prenylamin und Iproveratril. 2.